Health
Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission
Johnson & Johnson (NYSE: JNJ) today announced the launch of Generation Fine, a global campaign designed to challenge what it means to feel "fine" in depression care and empower patients to take the first step in moving beyond "good enough" by talking with their healthcare provider. Informed by a global survey of patients and healthcare providers spanning seven countries and four continents, the campaign reflects a troubling reality: nearly 4 in 5 patients living with major depressive disorder (M
About this update from Johnson & Johnson
[{"type":"text","content":"Generation Fine launches after global survey finds nearly 4 in 5 patients living with major depressive disorder don't believe antidepressants will help them reach remission","length":176,"tagName":"p"},{"type":"text","content":"Campaign draws on expertise of Mental Health America and elevates the voices of leading mental health advocates, including Kyle Long, television studio analyst, retired National Football League (NFL) player ","length":206,"tagName":"p"},{"type":"text","content":"NEW BRUNSWICK, N.J., May 7, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the launch of Generation Fine, a global campaign designed to challenge what it means to feel "fine" in depression care and empower patients to take the first step in moving beyond "good enough" by talking with their healthcare provider. Informed by a global survey of patients and healthcare providers spanning seven countries and four continents, the campaign reflects a troubling reality: nearly 4 in 5 patients living with major depressive disorder (MDD) don't believe antidepressants will help them reach remission. Developed in collaboration with leading mental health advocates and drawing on the expertise of Mental Health America, Generation Fine highlights the unique challenges and experiences of people living with depression and provides valuable resources to support more productive conversations about their care—including the possibility of remission.","length":989,"tagName":"p"},{"type":"text","content":""Depression doesn't look the same for everyone, but it is often treated with the same one-size-fits-all approach," said Jessica Jackson, Ph.D., Vice President of Alliance Development, Mental Health America. "This disconnect can leave people feeling unseen or misunderstood, while stigma and societal pressures make it even harder to seek help. We need to change the conversation and create opportunities where all people feel empowered to say, 'I'm not okay.'"","length":496,"tagName":"p"},{"type":"text","content":"MDD, or clinical depression, is one of the most common psychiatric disorders, affecting an estimated 332 million people worldwide.1,2 In the U.S. alone, more than 22 million adults live with the disorder.3 While oral antidepressants work for some, studies show that about 2 in 3...